Back to Atlas
CTransientStandard research/education caution
CMP-0406
Experimental
Orexin A
Eugeroic / Wakefulness
Wakefulness/arousal positioning
Reading this compound Reference only
Information below is educational. Dosing, mechanisms and status fields are compiled from the source list at the bottom of this page — always verify against a licensed clinician before use.
Reference-only summary of publicly discussed or source-listed patterns. Not medical advice and not a personal recommendation.
Mechanism & Use
- Compound type
- Neuropeptide
- Primary mechanism
- Orexin receptor agonism
- Primary market use
- Narcolepsy/wakefulness
Pharmacology
- Molecular weight (Da)
- 3561.2
- Oral bioavailability
- N/A
- Half-life
- minutes; not established
- Route tags
- SubQ; Injectable; route-dependent
- Evidence level
- Research
- Clinical status
- Experimental
- Value-for-money score
- 3 / 10
Reported protocol signal
No clean popular protocol found in uploaded sources; create as research/reference entry and verify before public protocol display.
For orientation only. See disclaimer — always consult a licensed clinician before use.
Notes
EveryChem-like peptide/eugeroic candidate; transient